Hematopoietic stem cell infusion ( DrugBank: - )

2 diseases

ID	Disease name (Link within this page)	Number of trials
19	Lysosomal storage disease	1
20	Adrenoleukodystrophy	1

19. Lysosomal storage disease

Clinical trials : 899 / Drugs : 684 - (DrugBank : 99) / Drug target genes : 51 - Drug target pathways : 182

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01372228 (ClinicalTrials.gov)	April 2011	10/6/2011	Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders	Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders	Hurler Syndrome (MPS I);Hurler-Scheie Syndrome;Hunter Syndrome (MPS II);Sanfilippo Syndrome (MPS III ...	Biological: hematopoietic stem cell infusion	Talaris Therapeutics Inc.	Duke University	Terminated	N/A	N/A	All	30	Phase 1/Phase 2	United States

Clinical trials : 61 / Drugs : 90 - (DrugBank : 31) / Drug target genes : 23 - Drug target pathways : 126

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01372228 (ClinicalTrials.gov)	April 2011	10/6/2011	Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders	Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders	Hurler Syndrome (MPS I);Hurler-Scheie Syndrome;Hunter Syndrome (MPS II);Sanfilippo Syndrome (MPS III ...	Biological: hematopoietic stem cell infusion	Talaris Therapeutics Inc.	Duke University	Terminated	N/A	N/A	All	30	Phase 1/Phase 2	United States